Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Belleview 402 LLC
483
•Belleview 402 LLC•March 15, 2024

Belleview 402 LLC – FDA 483, Mar 15, 2024

Record Details

An FDA inspection conducted at Wittman Pharma Inc. in Brooksville, FL, from February 6 to March 15, 2024, revealed significant deviations from Current Good Manufacturing Practices (CGMP) for drug manufacturers, resulting in a Form FDA 483. The inspection highlighted critical shortcomings in the firm's quality control systems and manufacturing processes, with several observations noted as repeats from previous inspections. Key issues included the absence of a properly established and followed quality control unit with adequate CGMP knowledge and oversight. The company failed to implement sufficient microbial controls for water used in liquid over-the-counter (OTC) drug products, despite historical recoveries of objectionable organisms and out-of-specification results. Furthermore, finished product testing was incomplete prior to the release and distribution of OTC drugs. The firm's water system, used in products for children, was not adequately qualified to consistently produce pharmaceutical-grade water, showing persistent microbial contamination. Additional observations noted incomplete cleaning validation for manufacturing equipment, deficiencies in laboratory controls such as insufficient microbial suitability testing and bulk product hold time studies, and inadequate identification testing of raw materials. Wittman Pharma Inc. must promptly address these serious observations to ensure product quality, safety, and compliance with regulatory standards.

Company
Belleview 402 LLC
Inspection date
March 15, 2024
Product type
drugs
Office
Office of Medical Device and Radiological Health Division II
People
  • Michael R Tolion
  • Saundrea A. Munroe (Drug Specialist / Drug Investigator)
  • Kayla V. Sprague (Pharmaceutical Investigator)
  • Michael H. Tollon (Approval Manager)
View Company Profile

ID · d3a350bd-3485-4351-806d-4b51a015b650

Other documents for Belleview 402 LLC
  • 483 - 2021-08-20August 20, 2021
  • 483 - 2019-02-15February 15, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Belleview 402 LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.